Cargando…
Genome-scale metabolic modeling reveals SARS-CoV-2-induced metabolic changes and antiviral targets
Tremendous progress has been made to control the COVID-19 pandemic caused by the SARS-CoV-2 virus. However, effective therapeutic options are still rare. Drug repurposing and combination represent practical strategies to address this urgent unmet medical need. Viruses, including coronaviruses, are k...
Autores principales: | Cheng, Kuoyuan, Martin-Sancho, Laura, Pal, Lipika R., Pu, Yuan, Riva, Laura, Yin, Xin, Sinha, Sanju, Nair, Nishanth Ulhas, Chanda, Sumit K., Ruppin, Eytan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7852273/ https://www.ncbi.nlm.nih.gov/pubmed/33532779 http://dx.doi.org/10.1101/2021.01.27.428543 |
Ejemplares similares
-
Genome‐scale metabolic modeling reveals SARS‐CoV‐2‐induced metabolic changes and antiviral targets
por: Cheng, Kuoyuan, et al.
Publicado: (2021) -
Synthetic lethality-based prediction of anti-SARS-CoV-2 targets
por: Pal, Lipika R., et al.
Publicado: (2021) -
Synthetic lethality-based prediction of anti-SARS-CoV-2 targets
por: Pal, Lipika R., et al.
Publicado: (2022) -
Synthetic lethality across normal tissues is strongly associated with cancer risk, onset, and tumor suppressor specificity
por: Cheng, Kuoyuan, et al.
Publicado: (2021) -
Cross-species identification of cancer resistance–associated genes that may mediate human cancer risk
por: Nair, Nishanth Ulhas, et al.
Publicado: (2022)